Modalis Therapeutics
4883.TTSE GROWTHPharmaceutical
Major holders (5%+) · 3
| Holder | Stake |
|---|---|
| Evo Fund | 7.61% |
| Life Science Innovation Management Inc. | 6.28% |
| LSIM Inc. | 5.02% |
Each holder's own ratio from its most recent large-shareholding report.
Former and minor holders (below 5%) · 5
| SBI SECURITIES Co., Ltd. | 3.77% |
| Osamu Nureki | 3.58% |
| SBI Investment Co., Ltd. | 0.69% |
| Haruhiko Morita | 0.38% |
| Evolution Capital Management LLC | 0.00% |
Ownership history · 177
| Holder | Ratio | Change |
|---|---|---|
| SBI Investment Co., Ltd.2024-04-26 · amended | 3.11% | -0.10pp |
| SBI SECURITIES Co., Ltd.2024-04-26 · amended | 2.57% | +1.17pp |
| SBI Investment Co., Ltd.2024-04-26 · amended | 3.21% | no change |
| Evolution Capital Management LLC2024-04-22 · amended | 0.00% | no change |
| Evo Fund2024-04-22 · amended | 22.88% | -5.71pp |
| SBI SECURITIES Co., Ltd.2024-04-11 · amended | 1.40% | -1.08pp |
| SBI Investment Co., Ltd.2024-04-11 · amended | 3.21% | no change |
| SBI SECURITIES Co., Ltd.2024-04-11 · amended | 2.48% | +1.03pp |
| SBI Investment Co., Ltd.2024-04-11 · amended | 3.21% | -0.25pp |
| SBI SECURITIES Co., Ltd.2024-04-10 · amended | 1.45% | -0.57pp |
| SBI Investment Co., Ltd.2024-04-10 · amended | 3.46% | -0.06pp |
| Evolution Capital Management LLC2024-03-13 · amended | 0.00% | no change |
| Evo Fund2024-03-13 · amended | 28.59% | -0.21pp |
| SBI SECURITIES Co., Ltd.2024-02-05 · amended | 2.02% | new |
| SBI Investment Co., Ltd.2024-02-05 · amended | 3.52% | new |
| Evolution Capital Management LLC2024-01-23 · amended | 0.00% | new |
| Evo Fund2024-01-23 · amended | 28.80% | new |
Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.